1700009C05Rik Inhibitors
Chemical inhibitors of 1700009C05Rik can play a significant role in modulating its function by targeting various signaling pathways that are crucial for its activity. Staurosporine, a well-known kinase inhibitor, can non-selectively inhibit a wide range of kinases by competing with ATP, therefore possibly affecting the phosphorylation state of 1700009C05Rik if it is a phosphorylation target. Similarly, LY294002 and Wortmannin are specific inhibitors of PI3K, a kinase that operates upstream in the PI3K/Akt pathway, which is known for regulating diverse cellular functions. By inhibiting PI3K, these chemicals can prevent the activation of Akt, a serine/threonine-specific protein kinase that may regulate the activity of 1700009C05Rik through phosphorylation. Consequently, the functional activity of 1700009C05Rik can be inhibited due to the disruption of the upstream signaling required for its activity.
Furthermore, Rapamycin, by inhibiting mTOR, can affect the activity of 1700009C05Rik if it is involved in mTOR-related signaling pathways. This inhibition occurs through the binding of Rapamycin to FKBP12, followed by the interaction with mTOR complex 1, which is central to cellular growth and metabolism. Other inhibitors such as PD98059 and U0126 target the MAPK/ERK pathway by inhibiting MEK, which in turn prevents the activation of ERK. If 1700009C05Rik is active downstream of this pathway, its activity would be inhibited due to the lack of ERK-mediated signaling. Similarly, SB203580 and SP600125 can block the p38 MAP kinase and JNK pathways, respectively. SB203580 can inhibit the activity of 1700009C05Rik by blocking p38 MAP kinase involved in stress response signaling, while SP600125 can inhibit JNK, affecting the phosphorylation of transcription factors that may regulate 1700009C05Rik. PP2, another inhibitor, targets Src family tyrosine kinases, which could lead to the inhibition of 1700009C05Rik if it is associated with Src kinase-mediated signaling pathways. The concerted inhibition of these kinases by PP2 would disrupt the signaling processes necessary for the functional activity of 1700009C05Rik.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is an ATP-competitive kinase inhibitor. By competing with ATP for binding to kinases, it can inhibit a wide range of kinases. Given that kinases are often upstream of signaling cascades, staurosporine can inhibit the phosphorylation of 1700009C05Rik. This prevents its activation or the propagation of signals that rely on phosphorylated forms of 1700009C05Rik. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a potent inhibitor of PI3K, which is involved in the PI3K/Akt pathway. By inhibiting PI3K, LY294002 prevents the phosphorylation and activation of Akt. Since the PI3K/Akt pathway is involved in a multitude of cellular processes, if 1700009C05Rik is regulated by this pathway, LY294002 would inhibit the functional activity of 1700009C05Rik by blocking the necessary upstream PI3K signaling. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor, like LY294002, and it exerts its inhibitory effect by covalently binding to and inhibiting PI3K. This inhibition can lead to a decrease in Akt phosphorylation and activity. If the function of 1700009C05Rik is dependent on the PI3K/Akt signaling pathway, the inhibition of PI3K by wortmannin would result in the functional inhibition of 1700009C05Rik. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor. By forming a complex with FKBP12, it binds to mTOR complex 1 (mTORC1) and inhibits its activity. Since mTOR is a central regulator of cellular growth and metabolism, if 1700009C05Rik's function is linked to these processes via mTOR signaling, rapamycin's inhibition of mTORC1 activity would lead to functional inhibition of 1700009C05Rik. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which is upstream of ERK in the MAPK/ERK pathway. By inhibiting MEK, PD98059 prevents the activation of ERK. If the functionality of 1700009C05Rik is dependent on the MAPK/ERK signaling pathway, the inhibition of MEK by PD98059 would prevent the downstream signaling required for the functional activity of 1700009C05Rik. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is also a MEK inhibitor, similar to PD98059. It prevents MEK from activating ERK, which is a critical step in the MAPK/ERK pathway. If 1700009C05Rik is functionally active downstream of this pathway, U0126's inhibition of MEK would lead to functional inhibition of 1700009C05Rik by blocking the necessary signaling events that rely on ERK activation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is an inhibitor of p38 MAP kinase. The p38 MAP kinase pathway is involved in the response to stress stimuli, such as cytokines and environmental stresses. If 1700009C05Rik operates within this pathway, the inhibition of p38 by SB203580 would inhibit the functional activity of 1700009C05Rik by preventing the signaling processes that are mediated through the p38 MAP kinase. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which is part of the stress-activated MAPK pathway. By inhibiting JNK, SP600125 can prevent the phosphorylation of c-Jun and the transcription of AP-1 target genes. If 1700009C05Rik is regulated by the JNK pathway, inhibition of JNK by SP600125 would result in the functional inhibition of 1700009C05Rik by blocking the necessary upstream JNK signaling. | ||||||